+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bone Health Supplements Market by Type, Dosage Form, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2025-2034

  • PDF Icon

    Report

  • 334 Pages
  • August 2025
  • Region: Global
  • Allied Market Research
  • ID: 6217999
Description Jump to:
The bone health supplements market was valued at $13.74 billion in 2024 and is estimated to reach $23.08 billion by 2034, exhibiting a CAGR of 5.3% from 2025 to 2034.

Dietary products that offer essential nutrients to improve bone strength and bone density are called bone health supplements. These supplements help manage conditions such as arthritis, osteoporosis, and age-related bone loss. These supplements also maintain the overall skeletal health of the patient.

Increase in prevalence of bone-related disorders, rise in health awareness, and surge in aging population boost the growth of the bone health supplements market. These supplements are available in the form of softgels, gummies, and others, which increase their popularity among the end users. Furthermore, changes in lifestyle and poor dietary habits reduce bone strength which results in the rise in demand of bone health supplements, thus boosting the market growth.

However, bone health supplements are available at a higher cost in the market. Also, there is an increase in the availability of counterfeit products in the market. These factors limit the growth of the market. There is an increase in awareness of preventive healthcare among the people. This increases the adoption of bone health supplements to strengthen bone strength. In addition, there is also an increase in the participation of sports and fitness activities, which also increases the consumption of these supplements. In addition, initiatives by the government and recommendations from healthcare professionals also foster the demand for bone health supplements in the market.

Segment Review

The bone health supplements market is segmented into type, dosage form, distribution channel, and region. On the basis of type, it is divided into vitamins, calcium, collagen, omega-3, glucosamine, and others. On the basis of dosage form, the market is segregated into tablets, capsules, powders, and others. On the basis of distribution channel, the market is categorized into pharmacies & drug stores, supermarkets/hypermarkets, online providers, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Key Takeaways

  • On the basis of type, the calcium segment accounted for the largest share in terms of revenue in 2024
  • On the basis of dosage form, the tablets segment accounted for the largest share in terms of revenue in 2024.
  • On the basis of distribution channel, the supermarkets/hypermarkets segment accounted for the largest share in terms of revenue in 2024
  • On the basis of region, North America dominated the market share in 2024

Competitive Analysis

The major companies profiled in the report include Amway, Bayer AG, Abbott Laboratories, Haleon Plc., Nestlé S.A., Nutramax Laboratories, Inc., Kirin Holdings (Blackmores), Herbalife, Otsuka Holdings Co. Ltd. (Pharmavite), and NOW Foods. The key players operating in the market have adopted product launch as their key strategies to expand their product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the bone health supplement market analysis from 2024 to 2034 to identify the prevailing market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the bone health supplement market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global bone health supplement market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly update with the purchase of an enterprise license.
  • 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
  • Free version update with the purchase of an Enterprise User License.
  • 16 hours of analyst support.
  • 15% free customization (Equivalent to 3 working days of work, applicable once).
  • Free data pack (Excel) with the purchase of an Enterprise User License.
  • Free updated report if the report is 6-12 months old or older.
  • 24-hour priority response.
  • Free industry updates and white papers.

Further possible customization (additional cost and timeline):

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles

Key Market Segments

By Type

  • Vitamins
  • Calcium
  • Collagen
  • Omega-3
  • Glucosamine
  • Others

By Dosage Form

  • Tablets
  • Capsules
  • Powder
  • Others

By Distribution Channel

  • Pharmacies and Drug Stores
  • Supermarkets or Hypermarkets
  • Online Providers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • NOW Foods
  • Haleon plc
  • Abbott Laboratories
  • Bayer AG
  • Amway Corp.
  • Nestle S.A.
  • Kirin Holdings
  • Nutramax Laboratories, Inc.
  • Herbalife
  • Otsuka Holdings Co., Ltd.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rising Geriatric Population and Osteoporosis Burden
3.4.1.2. Rise in Preventive Healthcare and Nutritional Deficiencies
3.4.1.3. Product Innovation and Distribution Expansion
3.4.2. Restraints
3.4.2.1. Safety Concerns and Side Effects
3.4.3. Opportunities
3.4.3.1. Growth Opportunities in Emerging Markets
CHAPTER 4: BONE HEALTH SUPPLEMENTS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Vitamins
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Calcium
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Collagen
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Omega-3
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Glucosamine
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Others
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
CHAPTER 5: BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM
5.1. Overview
5.1.1. Market size and forecast
5.2. Tablets
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Capsules
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Powder
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Pharmacies and Drug Stores
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Supermarkets or Hypermarkets
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Online Providers
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Others
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
CHAPTER 7: BONE HEALTH SUPPLEMENTS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Dosage Form
7.2.4. Market size and forecast, by Distribution Channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Dosage Form
7.2.5.1.3. Market size and forecast, by Distribution Channel
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Dosage Form
7.2.5.2.3. Market size and forecast, by Distribution Channel
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Dosage Form
7.2.5.3.3. Market size and forecast, by Distribution Channel
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Dosage Form
7.3.4. Market size and forecast, by Distribution Channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Dosage Form
7.3.5.1.3. Market size and forecast, by Distribution Channel
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Dosage Form
7.3.5.2.3. Market size and forecast, by Distribution Channel
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Dosage Form
7.3.5.3.3. Market size and forecast, by Distribution Channel
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Dosage Form
7.3.5.4.3. Market size and forecast, by Distribution Channel
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Dosage Form
7.3.5.5.3. Market size and forecast, by Distribution Channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Dosage Form
7.3.5.6.3. Market size and forecast, by Distribution Channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Dosage Form
7.4.4. Market size and forecast, by Distribution Channel
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Dosage Form
7.4.5.1.3. Market size and forecast, by Distribution Channel
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Dosage Form
7.4.5.2.3. Market size and forecast, by Distribution Channel
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Dosage Form
7.4.5.3.3. Market size and forecast, by Distribution Channel
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Dosage Form
7.4.5.4.3. Market size and forecast, by Distribution Channel
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Dosage Form
7.4.5.5.3. Market size and forecast, by Distribution Channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Dosage Form
7.4.5.6.3. Market size and forecast, by Distribution Channel
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Dosage Form
7.5.4. Market size and forecast, by Distribution Channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Dosage Form
7.5.5.1.3. Market size and forecast, by Distribution Channel
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Dosage Form
7.5.5.2.3. Market size and forecast, by Distribution Channel
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Dosage Form
7.5.5.3.3. Market size and forecast, by Distribution Channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Dosage Form
7.5.5.4.3. Market size and forecast, by Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2024
CHAPTER 9: COMPANY PROFILES
9.1. Amway Corp.
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Key strategic moves and developments
9.2. Bayer AG
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Abbott Laboratories
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Nutramax Laboratories, Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Haleon plc
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Herbalife
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. NOW Foods
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Kirin Holdings
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Otsuka Holdings Co., Ltd.
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Nestle S.A.
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 2. BONE HEALTH SUPPLEMENTS MARKET FOR VITAMINS, BY REGION, 2024-2034 ($MILLION)
TABLE 3. BONE HEALTH SUPPLEMENTS MARKET FOR CALCIUM, BY REGION, 2024-2034 ($MILLION)
TABLE 4. BONE HEALTH SUPPLEMENTS MARKET FOR COLLAGEN, BY REGION, 2024-2034 ($MILLION)
TABLE 5. BONE HEALTH SUPPLEMENTS MARKET FOR OMEGA-3, BY REGION, 2024-2034 ($MILLION)
TABLE 6. BONE HEALTH SUPPLEMENTS MARKET FOR GLUCOSAMINE, BY REGION, 2024-2034 ($MILLION)
TABLE 7. BONE HEALTH SUPPLEMENTS MARKET FOR OTHERS, BY REGION, 2024-2034 ($MILLION)
TABLE 8. GLOBAL BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 9. BONE HEALTH SUPPLEMENTS MARKET FOR TABLETS, BY REGION, 2024-2034 ($MILLION)
TABLE 10. BONE HEALTH SUPPLEMENTS MARKET FOR CAPSULES, BY REGION, 2024-2034 ($MILLION)
TABLE 11. BONE HEALTH SUPPLEMENTS MARKET FOR POWDER, BY REGION, 2024-2034 ($MILLION)
TABLE 12. BONE HEALTH SUPPLEMENTS MARKET FOR OTHERS, BY REGION, 2024-2034 ($MILLION)
TABLE 13. GLOBAL BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 14. BONE HEALTH SUPPLEMENTS MARKET FOR PHARMACIES AND DRUG STORES, BY REGION, 2024-2034 ($MILLION)
TABLE 15. BONE HEALTH SUPPLEMENTS MARKET FOR SUPERMARKETS OR HYPERMARKETS, BY REGION, 2024-2034 ($MILLION)
TABLE 16. BONE HEALTH SUPPLEMENTS MARKET FOR ONLINE PROVIDERS, BY REGION, 2024-2034 ($MILLION)
TABLE 17. BONE HEALTH SUPPLEMENTS MARKET FOR OTHERS, BY REGION, 2024-2034 ($MILLION)
TABLE 18. BONE HEALTH SUPPLEMENTS MARKET, BY REGION, 2024-2034 ($MILLION)
TABLE 19. NORTH AMERICA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 20. NORTH AMERICA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 21. NORTH AMERICA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 22. NORTH AMERICA BONE HEALTH SUPPLEMENTS MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 23. U.S. BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 24. U.S. BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 25. U.S. BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 26. CANADA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 27. CANADA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 28. CANADA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 29. MEXICO BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 30. MEXICO BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 31. MEXICO BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 32. EUROPE BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 33. EUROPE BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 34. EUROPE BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 35. EUROPE BONE HEALTH SUPPLEMENTS MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 36. GERMANY BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 37. GERMANY BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 38. GERMANY BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 39. FRANCE BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 40. FRANCE BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 41. FRANCE BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 42. UK BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 43. UK BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 44. UK BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 45. ITALY BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 46. ITALY BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 47. ITALY BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 48. SPAIN BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 49. SPAIN BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 50. SPAIN BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 51. REST OF EUROPE BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 52. REST OF EUROPE BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 53. REST OF EUROPE BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 54. ASIA-PACIFIC BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 55. ASIA-PACIFIC BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 56. ASIA-PACIFIC BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 57. ASIA-PACIFIC BONE HEALTH SUPPLEMENTS MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 58. JAPAN BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 59. JAPAN BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 60. JAPAN BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 61. CHINA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 62. CHINA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 63. CHINA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 64. INDIA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 65. INDIA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 66. INDIA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 67. AUSTRALIA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 68. AUSTRALIA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 69. AUSTRALIA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 70. SOUTH KOREA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 71. SOUTH KOREA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 72. SOUTH KOREA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 75. REST OF ASIA-PACIFIC BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 76. LAMEA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 77. LAMEA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 78. LAMEA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 79. LAMEA BONE HEALTH SUPPLEMENTS MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 80. BRAZIL BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 81. BRAZIL BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 82. BRAZIL BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 83. SAUDI ARABIA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 84. SAUDI ARABIA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 85. SAUDI ARABIA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 86. SOUTH AFRICA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 87. SOUTH AFRICA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 88. SOUTH AFRICA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 89. REST OF LAMEA BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024-2034 ($MILLION)
TABLE 90. REST OF LAMEA BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024-2034 ($MILLION)
TABLE 91. REST OF LAMEA BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024-2034 ($MILLION)
TABLE 92. AMWAY CORP.: KEY EXECUTIVES
TABLE 93. AMWAY CORP.: COMPANY SNAPSHOT
TABLE 94. AMWAY CORP.: PRODUCT SEGMENTS
TABLE 95. AMWAY CORP.: PRODUCT PORTFOLIO
TABLE 96. AMWAY CORP.: KEY STRATERGIES
TABLE 97. BAYER AG: KEY EXECUTIVES
TABLE 98. BAYER AG: COMPANY SNAPSHOT
TABLE 99. BAYER AG: PRODUCT SEGMENTS
TABLE 100. BAYER AG: PRODUCT PORTFOLIO
TABLE 101. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 102. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 103. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 104. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 105. NUTRAMAX LABORATORIES, INC.: KEY EXECUTIVES
TABLE 106. NUTRAMAX LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 107. NUTRAMAX LABORATORIES, INC.: PRODUCT SEGMENTS
TABLE 108. NUTRAMAX LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 109. HALEON PLC: KEY EXECUTIVES
TABLE 110. HALEON PLC: COMPANY SNAPSHOT
TABLE 111. HALEON PLC: PRODUCT SEGMENTS
TABLE 112. HALEON PLC: PRODUCT PORTFOLIO
TABLE 113. HERBALIFE: KEY EXECUTIVES
TABLE 114. HERBALIFE: COMPANY SNAPSHOT
TABLE 115. HERBALIFE: PRODUCT SEGMENTS
TABLE 116. HERBALIFE: PRODUCT PORTFOLIO
TABLE 117. NOW FOODS: KEY EXECUTIVES
TABLE 118. NOW FOODS: COMPANY SNAPSHOT
TABLE 119. NOW FOODS: PRODUCT SEGMENTS
TABLE 120. NOW FOODS: PRODUCT PORTFOLIO
TABLE 121. KIRIN HOLDINGS: KEY EXECUTIVES
TABLE 122. KIRIN HOLDINGS: COMPANY SNAPSHOT
TABLE 123. KIRIN HOLDINGS: PRODUCT SEGMENTS
TABLE 124. KIRIN HOLDINGS: PRODUCT PORTFOLIO
TABLE 125. OTSUKA HOLDINGS CO., LTD.: KEY EXECUTIVES
TABLE 126. OTSUKA HOLDINGS CO., LTD.: COMPANY SNAPSHOT
TABLE 127. OTSUKA HOLDINGS CO., LTD.: PRODUCT SEGMENTS
TABLE 128. OTSUKA HOLDINGS CO., LTD.: PRODUCT PORTFOLIO
TABLE 129. NESTLE S.A.: KEY EXECUTIVES
TABLE 130. NESTLE S.A.: COMPANY SNAPSHOT
TABLE 131. NESTLE S.A.: PRODUCT SEGMENTS
TABLE 132. NESTLE S.A.: PRODUCT PORTFOLIO
TABLE 133. NESTLE S.A.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1. BONE HEALTH SUPPLEMENTS MARKET, 2024-2034
FIGURE 2. SEGMENTATION OF BONE HEALTH SUPPLEMENTS MARKET,2024-2034
FIGURE 3. TOP IMPACTING FACTORS IN BONE HEALTH SUPPLEMENTS MARKET (2024 TO 2034)
FIGURE 4. TOP INVESTMENT POCKETS IN BONE HEALTH SUPPLEMENTS MARKET (2025-2034)
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. MODERATE THREAT OF SUBSTITUTES
FIGURE 8. MODERATE INTENSITY OF RIVALRY
FIGURE 9. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL BONE HEALTH SUPPLEMENTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. BONE HEALTH SUPPLEMENTS MARKET, BY TYPE, 2024 AND 2034(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR VITAMINS, BY COUNTRY 2024 AND 2034(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR CALCIUM, BY COUNTRY 2024 AND 2034(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR COLLAGEN, BY COUNTRY 2024 AND 2034(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR OMEGA-3, BY COUNTRY 2024 AND 2034(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR GLUCOSAMINE, BY COUNTRY 2024 AND 2034(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR OTHERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 18. BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM, 2024 AND 2034(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR TABLETS, BY COUNTRY 2024 AND 2034(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR CAPSULES, BY COUNTRY 2024 AND 2034(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR POWDER, BY COUNTRY 2024 AND 2034(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR OTHERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 23. BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024 AND 2034(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR PHARMACIES AND DRUG STORES, BY COUNTRY 2024 AND 2034(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR SUPERMARKETS OR HYPERMARKETS, BY COUNTRY 2024 AND 2034(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR ONLINE PROVIDERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF BONE HEALTH SUPPLEMENTS MARKET FOR OTHERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 28. BONE HEALTH SUPPLEMENTS MARKET BY REGION, 2024 AND 2034(%)
FIGURE 29. U.S. BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 30. CANADA BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 31. MEXICO BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 32. GERMANY BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 33. FRANCE BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 34. UK BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 35. ITALY BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 36. SPAIN BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 37. REST OF EUROPE BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 38. JAPAN BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 39. CHINA BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 40. INDIA BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 41. AUSTRALIA BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 42. SOUTH KOREA BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 43. REST OF ASIA-PACIFIC BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 44. BRAZIL BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 45. SAUDI ARABIA BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 46. SOUTH AFRICA BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 47. REST OF LAMEA BONE HEALTH SUPPLEMENTS MARKET, 2024-2034 ($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR (2022-2024)
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022-2024)
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY (2022-2024)
FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52. COMPETITIVE DASHBOARD
FIGURE 53. COMPETITIVE HEATMAP: BONE HEALTH SUPPLEMENTS MARKET
FIGURE 54. TOP PLAYER POSITIONING, 2024
FIGURE 55. BAYER AG: NET SALES, 2022-2024 ($MILLION)
FIGURE 56. BAYER AG: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 57. BAYER AG: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 58. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
FIGURE 59. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 60. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 61. HALEON PLC: NET SALES, 2022-2024 ($MILLION)
FIGURE 62. HERBALIFE: NET SALES, 2022-2024 ($MILLION)
FIGURE 63. HERBALIFE: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 64. HERBALIFE: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 65. KIRIN HOLDINGS: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 66. OTSUKA HOLDINGS CO., LTD.: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 67. OTSUKA HOLDINGS CO., LTD.: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 68. OTSUKA HOLDINGS CO., LTD.: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 69. NESTLE S.A.: NET SALES, 2022-2024 ($MILLION)
FIGURE 70. NESTLE S.A.: REVENUE SHARE BY REGION, 2024 (%)

Companies Mentioned

  • NOW Foods
  • Haleon plc
  • Abbott Laboratories
  • Bayer AG
  • Amway Corp.
  • Nestle S.A.
  • Kirin Holdings
  • Nutramax Laboratories, Inc.
  • Herbalife
  • Otsuka Holdings Co., Ltd.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

Vitamin K2 Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Vitamin K2 Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From
Bone and Joint Health Supplements Market Report 2025 - Product Image

Bone and Joint Health Supplements Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Japan Dietary Supplements Market Report and Forecast 2025-2034 - Product Image

Japan Dietary Supplements Market Report and Forecast 2025-2034

  • Report
  • 250 Pages
  • Japan
From
Men's Health Supplements Market Report 2025 - Product Image

Men's Health Supplements Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Liquid Dietary Supplements Market Report and Forecast 2025-2034 - Product Image

Liquid Dietary Supplements Market Report and Forecast 2025-2034

  • Report
  • 165 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.